drugset / Trial / NCT05170672

Expanded Access for Abatacept

NCT05170672 ↗

Expanded access No longer available Bristol-Myers Squibb

Summary

This is an expanded access designed to provide access to abatacept for eligible participants.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Abatacept Other / unclassified — —

Indications

No indication recorded.